{
  "schema": "pestle.medicine.v1",
  "url": "https://pestle.health/uk/empagliflozin",
  "country": "GB",
  "medicine": "Empagliflozin",
  "activeIngredient": "empagliflozin",
  "source": {
    "type": "Patient information leaflet approved by the UK medicines regulator (MHRA)",
    "product": "Empagliflozin 25 mg Film-Coated Tablets",
    "licenceNumber": "PL 16363/0907",
    "url": "https://mhraproducts4853.blob.core.windows.net/docs/5b441fc69a915eda573bb46d7e0c19332c0a0efd",
    "leafletDate": "2026-10-16"
  },
  "checkedAgainstSource": "2026-11-19",
  "automatedCheck": {
    "sideEffectsListed": 18,
    "wordingFoundInLeaflet": 18,
    "notFound": 0
  },
  "reviewedBy": null,
  "whatItIsFor": "Empagliflozin is an SGLT2 inhibitor medicine. It is used to treat type 2 diabetes in adults and children aged 10 years and older when diet and exercise alone are not enough, and to treat heart failure and chronic kidney disease in adults.",
  "keyFacts": [
    "It lowers blood sugar by making your kidneys remove sugar in your urine, so your urine will test positive for sugar.",
    "Keep following the diet and exercise plan your doctor has given you.",
    "Contact a doctor or the nearest hospital straight away if you have signs of ketoacidosis, such as rapid weight loss, feeling or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion or a sweet smell on your breath.",
    "Your kidneys should be checked before you start and while you take this medicine.",
    "Do not stop taking it without speaking to your doctor, unless you suspect ketoacidosis."
  ],
  "doNotTake": [
    "If you are allergic to empagliflozin or any of the other ingredients of this medicine"
  ],
  "checkWithDoctorFirst": [
    "Ketoacidosis symptoms: contact a doctor or hospital straight away and stop taking the medicine until advised",
    "Risk of ketoacidosis may be higher with prolonged fasting, excessive alcohol, dehydration, sudden reductions in insulin dose, or a higher need for insulin due to major surgery or serious illness",
    "Type 1 diabetes: you should not take empagliflozin",
    "Serious kidney problems: your doctor may limit your dose to 10 mg once a day or give a different medicine",
    "Serious liver problems: your doctor may give a different medicine",
    "Risk of dehydration, for example being sick, having diarrhoea or fever, not being able to eat or drink, taking diuretics or blood pressure lowering medicines, or being 75 or older",
    "Serious infection of the kidney or urinary tract with fever: your doctor may ask you to stop until you recover",
    "Pain, tenderness, redness or swelling of the genitals or the area between the genitals and the anus with fever or feeling unwell: talk to your doctor immediately (possible Fournier's gangrene)",
    "Check your feet regularly and follow foot care advice",
    "Your urine will test positive for sugar while taking this medicine",
    "Not recommended under 18 years for heart failure or chronic kidney disease; no data for children under 10 years with type 2 diabetes",
    "Contains lactose: speak to your doctor if you have been told you have an intolerance to some sugars"
  ],
  "seriousSideEffects": [
    "Severe allergic reaction, such as swelling of the face, lips, mouth, tongue or throat that may lead to difficulty breathing or swallowing (uncommon)",
    "Ketoacidosis (uncommon)",
    "Necrotising fasciitis of the perineum or Fournier's gangrene (rare)"
  ],
  "sideEffectsByFrequency": [
    {
      "frequency": "Very common",
      "meaning": "More than 1 in 10 people",
      "effects": [
        "Low blood sugar (hypoglycaemia)",
        "Dehydration"
      ]
    },
    {
      "frequency": "Common",
      "meaning": "Up to 1 in 10 people",
      "effects": [
        "Urinary tract infection",
        "Genital yeast infection (thrush)",
        "Passing more urine than usual or needing to pass urine more often",
        "Itching",
        "Rash or red skin",
        "Thirst",
        "Increase in blood fat (cholesterol) levels in blood tests",
        "Constipation"
      ]
    },
    {
      "frequency": "Uncommon",
      "meaning": "Up to 1 in 100 people",
      "effects": [
        "Severe allergic reaction",
        "Ketoacidosis",
        "Hives",
        "Straining or pain when emptying the bladder",
        "Decrease in kidney function (creatinine or urea) in blood tests",
        "Increases in the amount of red blood cells (haematocrit) in blood tests"
      ]
    },
    {
      "frequency": "Rare",
      "meaning": "Up to 1 in 1,000 people",
      "effects": [
        "Necrotising fasciitis of the perineum or Fournier's gangrene"
      ]
    },
    {
      "frequency": "Very rare",
      "meaning": "Up to 1 in 10,000 people",
      "effects": [
        "Inflammation of the kidneys (tubulointerstitial nephritis)"
      ]
    }
  ],
  "otherMedicinesTheLeafletMentions": [
    "Medicines that increase urine production (diuretics)",
    "Other medicines that lower blood sugar, such as insulin or a sulphonylurea medicine",
    "Lithium"
  ],
  "pregnancyAndBreastfeeding": "Do not use empagliflozin if you are pregnant, as it is unknown whether it is harmful to the unborn child. Do not use it if you are breast-feeding, as it is not known whether it passes into breast milk. Ask your doctor or pharmacist for advice if you are pregnant, think you may be, or are planning a baby.",
  "howToTake": [
    "The recommended dose is one 10 mg tablet once a day; for type 2 diabetes your doctor may increase it to 25 mg once a day if needed.",
    "Your doctor may limit your dose to 10 mg once a day if you have a kidney problem.",
    "Swallow the tablet whole with water, with or without food, at any time of day, but try to take it at the same time each day.",
    "If you miss a dose and it is 12 hours or more until the next one, take it when you remember; if it is less than 12 hours, skip it. Never take a double dose.",
    "Do not change your dose or stop taking it unless your doctor tells you to."
  ],
  "notice": "Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets."
}